BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...
April 25, 2012 (Denver, Colorado) — A new study on the use of dual- and single-chamber implantable cardioverter defibrillators (ICDs) in patients without a pacemaker indication highlights the critical ...
The introduction of dual-chamber pacing in current ICD has facilitated and improved the treatment of ICD recipients with concomitant standard dual-chamber pacemaker indication. Whether dual-chamber ...
BIOTRONIK has announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System. This novel device is a first-in-class implantable cardiac defibrillator ...
Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable ...
LAKE OSWEGO, Oregon, – BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has approved a significant expansion of its ...
Biotronik, a leading manufacturer of cardiovascular medical technology that offers the world's largest portfolio of ProMRI cardiac implants, has launched its Iperia 7 VR-T DX ProMRI single-chamber ...
Visia AF MRI (TM) SureScan ® and Visia AF (TM) ICDs Treat Dangerous Heart Rhythms and Enable Physicians to Identify Patients at Increased Risk for Stroke and Heart Failure Due to AF DUBLIN., Medtronic ...
EnRhythm(TM) pacemaker and EnTrust(TM) defibrillators now available in Europe Medtronic, Inc. (NYSE:MDT) today announced the European introductions of the Medtronic EnRhythm(TM) pacemaker ...